Skip to content

Clinical Manual of Child and Adolescent Psychopharmacology, Fourth Edition

Edited by Molly McVoy, M.D., Ekaterina Stepanova, M.D., Ph.D., and Robert L. Findling, M.D., M.B.A.

  • 2024
  • 524 Pages
  • ISBN 978-1-61537-489-2
  • Item #37489

View Pricing

List Price
$83.00

APA Members
$66.40

20% off

APA Resident-Fellow Members
$62.25

25% off

Buying In Canada or Europe?

Description

Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology not only examines the evidence for treating mental health disorders in younger patients but also illuminates how clinical trials of various methodologies can inform different aspects of clinical practice.

Organized by DSM-5-TR diagnosis rather than drug class, this clinically accessible volume offers an exhaustive analysis of the use of psychotropic agents in disorders that include

  • Attention-deficit/hyperactivity disorder
  • Depressive disorders
  • Autism spectrum disorder
  • Early schizophrenia and psychotic illnesses
  • Eating disorders

Comprehensive medication tables allow for easy reference of dosing, side effects, and tips for management. Additionally, key points at the conclusion of each chapter summarize essential information for treating clinicians.

With a depth of information unmatched by any other guide, this new edition of the Clinical Manual of Child and Adolescent Psychopharmacology is an indispensable desktop reference for clinicians working with young patients.

Contents

  • Foreword
  • Preface
  • Chapter 1. Developmental Aspects of Pediatric Psychopharmacology
  • Chapter 2. Attention-Deficit/Hyperactivity Disorder
  • Chapter 3. Disruptive Behavior Disorders and Aggression
  • Chapter 4. Anxiety Disorders
  • Chapter 5. Major Depressive Disorder
  • Chapter 6. Bipolar Disorders
  • Chapter 7. Autism Spectrum Disorder
  • Chapter 8. Tic Disorders
  • Chapter 9. Early-Onset Schizophrenia and Psychotic Illnesses
  • Chapter 10. Eating Disorders

Contributors

    Boris Birmaher, M.D.
    Chiara Davico, M.D.
    Roxanne Demarest, P.A.-C.
    David I. Driver, M.D.
    Mina K. Dulcan, M.D.
    Robert L. Findling, M.D., M.B.A.
    Nitin Gogtay, M.D.
    Pablo H. Goldberg, M.D.
    Laurence Greenhill, M.D.
    Peter S. Jensen, M.D.
    Christopher J. Keary, M.D.
    Sarah Lytle, M.D.
    Daniele Marcotulli, M.D., Ph.D.
    Christopher J. McDougle, M.D.
    Molly McVoy, M.D.
    Basim Mikhail, M.D.
    Michelle L. Palumbo, M.D.
    Stephanie Pope, M.D.
    Judith L. Rapoport, M.D.
    Manivel Rengasamy, Ph.D.
    Moira A. Rynn, M.D.
    Lawrence Scahill, M.S.N., Ph.D.
    Lauren Schumacher, M.D.
    Ekaterina Stepanova, M.D., Ph.D.
    Griffin Stout, M.D.
    Tiffany Thomas-Lakia, M.D.
    Benedetto Vitiello, M.D.
    Paula K. Yanes-Lukin, Ph.D.
    Solomon G. Zaraa, D.O.

About the Authors

Molly McVoy, M.D., is an Associate Professor in psychiatry in the division of Child and Adolescent Psychiatry Fellowship at University Hospitals/Case Western Reserve University in Cleveland, Ohio.

Ekaterina Stepanova, M.D, Ph.D., is Chair of Child and Adolescent Psychiatry at Virginia Treatment Center for Children in Richmond, Virginia.

Robert L. Findling, M.D., M.B.A., is Chair of the Department of Psychiatry at Virginia Commonwealth University in Richmond, Virginia.

Related Products

Become an APA Member
Join Now